The Clinical Handbook of Child and Adolescent Psychiatry: A DSM 5 TR Guide to Diagnosis, Evidence Based Treatment, plus Pharmacotherapy in Pediatric Mental Health

Invasive fungal infections continue to climb across hospital populations — immunocompromised patients, transplant recipients, neonatal and pediatric wards, and surgical units all face increasing exposure to organisms that look maddeningly similar under the microscope yet demand entirely different therapeutic responses. The cost of misidentification is measured in delayed therapy, inappropriate antifungal selection, prolonged hospitalizations, and patient outcomes that should never have happened.

This atlas was built for the clinician who needs to recognize the organism in front of them with confidence and act on that recognition without hesitation. Detailed visual references for yeasts, molds, and dimorphic pathogens sit alongside the morphological clues that distinguish them, integrated with current antifungal selection principles, susceptibility considerations, and clinical decision pathways that translate pathogen recognition into actionable treatment at the bedside.

Whether you practice clinical microbiology, infectious disease, hematology-oncology, transplant medicine, critical care, or pharmacy advisory services, this reference puts pathogen identification and antifungal decision-making in the same place — where they have always belonged but rarely been found together.

Inside this clinical reference:

• Detailed morphological identification of medically important yeasts — Candida species, Cryptococcus, Trichosporon, Rhodotorula, and emerging pathogens including Candida auris — with the distinguishing features that matter at the bench, on chromogenic media, and under microscopy

• Visual recognition of common and uncommon mold pathogens — Aspergillus species variations, the Mucorales, Fusarium, Scedosporium, Lomentospora, and the dematiaceous molds — with colony morphology, microscopic features, and growth characteristics that drive accurate identification

• Comprehensive coverage of dimorphic fungal pathogens — Histoplasma, Blastomyces, Coccidioides, Paracoccidioides, Talaromyces, and Sporothrix — with geographic distribution, clinical presentation patterns, and laboratory hazards that demand specific containment protocols

• Current antifungal selection guidance across azoles, echinocandins, polyenes, and emerging agents — including drug-pathogen matching, susceptibility breakpoints, pharmacokinetics, therapeutic drug monitoring, and clinically significant drug-drug interactions

• Clinical decision frameworks for empiric versus targeted therapy in invasive candidiasis, invasive aspergillosis, mucormycosis, cryptococcal disease, and endemic mycoses across immunocompetent and immunocompromised hosts

• Diagnostic pathway integration — when to deploy direct microscopy, culture, antigen detection, beta-D-glucan, galactomannan, molecular methods, and histopathology, and how to reconcile discordant results across modalities

• Antifungal stewardship principles, resistance pattern awareness, breakthrough infection management, and dosing adjustments for special populations including pediatric, pregnancy, renal impairment, and hepatic dysfunction integrated throughout

Buy Now and arm your clinical practice with the diagnostic precision modern mycology demands.

Every fungal diagnostic challenge presents two choices — guess and hope, or recognize and act. This reference exists for clinicians who refuse to leave their patients' outcomes to the first option. Make the second your default.